Lupus Nephritis: How well does Obinutuzumab protect Kidney Function?

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
AKTUELLE RHEUMATOLOGIE | 2024年 / 49卷 / 05期
关键词：
D O I：
10.1055/a-2305-7459
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A crucial long-term therapeutic goal in lupus nephritis is to preserve renal function with the lowest possible use of glucocorticoids. Can this be achieved by supplementing standard treatment with obinutuzumab, a recombinant, monoclonal, humanized type II anti-CD20 IgG1 antibody? An international team of researchers investigated this question in a post-hoc analysis of data from the NOBILITY study.
引用
收藏
页码：280 / 281
页数：2
相关论文
共 50 条
  • [41] Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis
    Gatto, Mariele
    Frontini, Giulia
    Calatroni, Marta
    Reggiani, Francesco
    Depascale, Roberto
    Cruciani, Claudio
    Quaglini, Silvana
    Sacchi, Lucia
    Trezzi, Barbara
    Bonelli, Grazia Dea
    L'Imperio, Vincenzo
    Vaglio, Augusto
    Furlan, Claudia
    Zen, Margherita
    Iaccarino, Luca
    Sinico, Renato Alberto
    Doria, Andrea
    Moroni, Gabriella
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (04): : 1047 - 1056
  • [42] HOW WELL DO CLINICAL TRIALS REPRESENT REAL WORLD LUPUS NEPHRITIS PATIENTS?
    Collinson, Sophie
    Parker, Ben
    Mccarthy, Eoghan
    Bruce, Ian N.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 760 - 760
  • [43] How to manage patients with lupus nephritis
    Esdaile, JM
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2002, 16 (02): : 195 - 210
  • [44] Alternative Renal Response Definitions in a Randomized, Controlled Trial of Obinutuzumab for Proliferative Lupus Nephritis
    Amoura, Zahir
    Remy, Philippe
    Quintana Porras, Luis Fernando
    Chiche, Laurent
    Chauveau, Dominique
    Roccatello, Dario
    Furie, Richard
    Schindler, Thomas
    Garg, Jay
    Cascino, Matthew
    Rovin, Brad
    Doria, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [45] ALTERNATIVE RENAL RESPONSE DEFINITIONS IN A RANDOMIZED, CONTROLLED TRIAL OF OBINUTUZUMAB FOR PROLIFERATIVE LUPUS NEPHRITIS
    Amoura, Z.
    Remy, P.
    Quintana Porras, L. F.
    Chiche, L.
    Chauveau, D.
    Roccatello, D.
    Furie, R.
    Schindler, T.
    Garg, J.
    Cascino, M. D.
    Rovin, B. H.
    Doria, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 104 - 105
  • [46] Cyclophosphamide and Lupus Nephritis: When, How, For How Long?
    Ntali, Stella
    Bertsias, George
    Boumpas, Dimitrios T.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2011, 40 (03) : 181 - 191
  • [47] Cyclophosphamide and Lupus Nephritis: When, How, For How Long?
    Stella Ntali
    George Bertsias
    Dimitrios T. Boumpas
    Clinical Reviews in Allergy & Immunology, 2011, 40 : 181 - 191
  • [48] SGLT2 inhibitors protect podocytes in lupus nephritis
    Sarah Onuora
    Nature Reviews Rheumatology, 2023, 19 : 605 - 605
  • [49] SGLT2 inhibitors protect podocytes in lupus nephritis
    Onuora, Sarah
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (10) : 605 - 605
  • [50] Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis
    Moroni, Gabriella
    Porata, Giulia
    Raffiotta, Francesca
    Frontini, Giulia
    Calatroni, Marta
    Reggiani, Francesco
    Banfi, Giovanni
    Ponticelli, Claudio
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
12345